Send to

Choose Destination
Biosci Trends. 2019 Mar 14;13(1):23-31. doi: 10.5582/bst.2018.01247. Epub 2019 Feb 27.

Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury.

Author information

Department of General Surgery, Second Affiliated Hospital of Xi'an Jiaotong University.
The High School Affiliated to xi'an Jiaotong University.


Cholestasis is a pathological process in which bile drainage is poor for a variety of reasons. Many studies have shown that cholestatic liver injury is a neutrophil-mediated inflammatory response, and oxidative stress induced by neutrophils is the main mechanism of liver cell death. The literature summarizes the bile acid signaling pathway, the neutrophil chemotaxis recruitment process during cholestasis, and the oxidative stress damage produced by neutrophil activation, summarizes the latest research progress. Sphingosine-1-phosphate receptor (S1PR) is a potential therapeutic target for cholestasis that reduces neutrophil aggregation without inhibiting systemic immune status. Early growth response factor 1 (Egr-1) may play a central role in the inflammation induced by cholestasis, and it is also a potential therapeutic target to inhibit the inflammation induced by cholestasis. Strengthening the antioxidant system of hepatocytes to cope with oxidative stress of neutrophils is a feasible treatment for cholestatic liver injury.


Cholestatic liver injury; early growth response factor 1; sphingosine-1-phosphate receptor

Free full text

Supplemental Content

Full text links

Icon for J-STAGE, Japan Science and Technology Information Aggregator, Electronic
Loading ...
Support Center